Moody Aldrich Partners LLC Sells 6,767 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Moody Aldrich Partners LLC lowered its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 9.2% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 66,866 shares of the company’s stock after selling 6,767 shares during the period. Moody Aldrich Partners LLC owned approximately 0.14% […]

Related Keywords

Washington ,United States ,China ,Markl Jacobson ,Roger Jeffs ,Piper Sandler ,Baldwin Brothers ,China Universal Asset Management Co ,Nasdaq ,Cantor Fitzgerald ,Securities Exchange Commission ,Axsome Therapeutics Company Profile ,Sg Americas Securities ,Moody Aldrich Partners ,Citigroup ,Axsome Therapeutics Inc ,Washington Trust Advisors Inc ,Axsome Therapeutics ,Free Report ,Aldrich Partners ,Universal Asset Management ,Trust Advisors ,Director Roger Jeffs ,Exchange Commission ,Therapeutics Trading Down ,Get Free Report ,Axsome Therapeutics Daily ,Nasdaq Axsm ,Axsm ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,